Adults in the U.S. have overtaken children in taking medication for the condition and accounted for 53 percent of the industrywide 63 million prescriptions for ADHD drugs last year, according to data compiled by Shire Plc, which makes the top-selling Vyvanse treatment. Bloomberg’s Betty Liu and mark Crumpton report on “Bloomberg Markets.”
Hey, check out all the research scientist jobs. Post your resume today!
